Kenon Shareholders Re-Elect All Directors, Renew Share Buyback Authorization
Kenon Holdings Ltd. shareholders re-elected all nine incumbent directors at the Annual General Meeting, ensuring continuity in leadership. Investors also approved the renewal of the company’s share purchase authorization, alongside authorizations for share issuances and incentive plan awards.
AI Headshots
Sponsored
Turn 3 selfies into professional photos with AI Headshots.
Happiness guaranteed. Learn more.
OMAB's June 2025 Traffic: 8.5% Growth Signals Robust Air Travel Demand
Central North Airport (OMA) reported an 8.5% increase in terminal passenger traffic for June 2025 compared to the previous year, driven by a notable 10.5% surge in international travelers. This strong growth across its 13 Mexican airports, coupled with the launch of two new routes, signals robust and sustained demand for air travel in its network.
Delayed 10-K Triggers Nasdaq Notice for PetMed Express
PetMed Express has received a Nasdaq notice of non-compliance for its failure to timely file its Annual Report on Form 10-K for fiscal year ended March 31, 2025, initiating a compliance process that requires a plan by September 1, 2025, though the company's listing is not immediately affected.
100 Basis Point Drop: Capital One's Stress Capital Buffer Reduced to 4.5%
Capital One announced its preliminary Stress Capital Buffer (SCB) requirement for 2025 has been reduced to 4.5% from the prior 5.5%, effective October 1, 2025. This 100 basis point reduction, determined by the Federal Reserve's CCAR process, potentially offers Capital One greater capital flexibility.
InterContinental Hotels' Treasury Holds Over 6 Million Shares Amid Buyback Drive
InterContinental Hotels reported its total voting rights at 154.7 million as of June 30, 2025, reflecting an ongoing share repurchase program that has placed over 6.2 million shares into treasury for cancellation. This strategic move aims to reduce the outstanding share count, aligning with shareholder authorization from the recent Annual General Meeting.
Credit Confidence: S&P Lifts Edenor's Rating from CCC+ to B-
Edenor, an Argentine electricity distributor, saw its S&P credit rating upgraded from CCC+ to B- with a stable outlook. This improvement signals enhanced creditworthiness, potentially lowering borrowing costs and expanding access to capital for the nearly $1.65 billion market cap company.
UNFI's Cyber Recovery: Systems Restored, But Q4 Earnings Face Material Headwind
United Natural Foods, a key distributor of natural and organic foods, expects a material hit to its Q4 2025 net income and adjusted EBITDA due to a recent cybersecurity incident, though operations have normalized and long-term financial objectives remain on track. The company's prompt response contained the activity, and it anticipates adequate coverage from cybersecurity insurance.
Pharming-Backed Study Reshapes APDS Diagnosis, Hints at Broader Prevalence
Pharming announced a new *Cell* study's findings that promise to accelerate diagnosis for Activated Phosphoinositide 3-Kinase delta (APDS) by reclassifying genetic variants, potentially expanding the addressable market for its drug Leniolisib.
Ryanair Buys Back Over 250,000 Shares for Cancellation
Ryanair repurchased 253,581 ordinary shares and shares underlying American Depositary Shares (ADSs) between June 9 and June 13, 2025, for cancellation. This $7.1 million buyback is part of an ongoing program aimed at reducing outstanding shares and enhancing shareholder value.
U.S. GoldMining Unearths Untapped Gold Potential: Muddy Creek Samples Reveal 111.5 g/t Au
U.S. GoldMining revealed significant high-priority exploration targets at its Muddy Creek area in Alaska, highlighting historic rock grab samples with peak gold values up to 111.50 g/t Au.
Despite these high-grade surface indications, the company notes that the most prospective parts of the system remain undrilled, with future exploration programs, including drilling, planned.
Phoenix Asia's Swift Auditor Change Reveals Key Internal Control Flaws
Phoenix Asia has abruptly changed its independent registered public accounting firm, with ARK Pro CPA & Co resigning and J&S Associate PLT taking over. The outgoing auditor, ARK Pro, cited significant material weaknesses in Phoenix Asia's internal controls, including a lack of US GAAP expertise and a functional internal audit department.
VinFast Delivers Over 11,000 EVs in Vietnam for May, Totaling 56,187 Year-to-Date
VinFast Auto delivered 11,496 electric vehicles in Vietnam during May 2025, bringing its year-to-date domestic deliveries to 56,187 units and reinforcing its leading position in the local EV market.
Cybin Fortifies CYB004 Program with Key U.S. Patent, Extending Exclusivity to 2040
Cybin secured a key U.S. patent for its CYB004 program, a Phase 2 therapy for generalized anxiety disorder, providing intellectual property exclusivity until 2040. This new patent enhances Cybin's growing portfolio of over 90 granted patents and supports its goal to deliver rapid-acting, patient-friendly treatments.
Seabridge Gold Kicks Off $13.4 Million Iskut Drill Program Targeting Maiden Cu-Au Resource
Seabridge Gold has launched its 2025 drill program at the Iskut Project's Snip North discovery in British Columbia, committing $13.4 million to delineate copper-gold mineralization and pursue a maiden resource estimate, while also exploring district-scale porphyry targets.
Colombia's First Hard-Rock Tungsten Discovery: Collective Mining's Apollo Reveals 124 Meters at 3.03 g/t AuEq
Collective Mining has expanded its Apollo system with new high-grade drilling results, notably uncovering the first known hard-rock tungsten in Colombia, a strategic metal commanding high prices. This discovery, found alongside gold, silver, and copper, includes a significant intercept of 124 meters at 3.03 g/t gold equivalent from surface, enhancing the project's early mine-life potential.
Rapport Therapeutics: RAP-219 Phase 2a Epilepsy Trial Fully Enrolled, September Readout Set
Rapport Therapeutics announced its RAP-219 Phase 2a trial for refractory focal epilepsy is fully enrolled, with topline results expected in September 2025. The company also highlighted strong Phase 1 safety data for RAP-219, showing only mild-to-moderate adverse events and no serious issues, reinforcing its precision neuroscience platform.
First Majestic Silver Strikes High-Grade Gold-Silver at Santo Niño, Expands Navidad Deposit
First Majestic Silver announced a new gold-silver discovery, Santo Niño, and expanded high-grade mineralization at Navidad within its Santa Elena property in Mexico. These developments add to the district's growing potential, potentially extending mine life and unlocking additional value for the company.
NexGen Unearths World's Highest-Grade Uranium Vein Intercept: 68.8% U₃O₈ at Patterson Corridor East
NexGen Energy announced its highest-grade discovery phase assay results from Patterson Corridor East, including an exceptional 0.5-meter intercept at 68.8% U₃O₈ in drillhole RK-25-232.
This further validates the scale and continuity of the mineralization near the future Rook I Project, bolstering NexGen's role in meeting global nuclear fuel demand.
New Found Gold Hits 42.8 g/t Au Over 14.95m, Expands Queensway Gold Zones
New Found Gold announced high-grade drill results from its Queensway Gold Project, including 42.8 g/t Au over 14.95 meters and 47.6 g/t Au over 3.95 meters at the Dropkick zone, expanding its known extent and identifying a new domain.
Additional results from the Pistachio and AFZ Peripheral zones demonstrate continued mineralization and identify new targets for follow-up drilling planned for Q2 2025.
Nutex Health Replaces Auditor, Cites Material Weaknesses in Financial Controls
Nutex Health has appointed Grant Thornton LLP as its new independent auditor, replacing CBIZ CPAs P.C. The change follows a selection process and comes after CBIZ identified material weaknesses in Nutex Health's internal financial controls.
Carter Bankshares Board Authorizes $20 Million Share Repurchase Program
Carter Bankshares' board has authorized a new share repurchase program, permitting the company to buy back up to $20 million of its common stock through May 14, 2026. Purchases will be discretionary and depend on market and financial conditions.
Contango ORE Reports $225 Million Post-Tax NPV and One Year Payback for Johnson Tract Project
Contango ORE announced the results of a Technical Report Summary for its Johnson Tract Project, revealing robust economics from an Initial Assessment. The report projects a post-tax NPV of $225 million and a rapid 1.3-year payback based on a $2,200 per ounce gold price, with low estimated initial capital costs of $214 million and all-in sustaining costs of $860 per gold equivalent ounce.
ON24 Prioritizes $50 Million Buyback, Holds Off on Dividends Amidst Net Losses
ON24 does not pay dividends due to a history of net losses, despite generating positive operating free cash flow in the first quarter of 2025. The company is instead prioritizing shareholder returns through a recently approved $50 million share repurchase program, supported by a solid $181 million cash position and no debt.
Cyber Incident Disrupts Masimo Manufacturing, Order Fulfillment
Masimo reported a cyber incident detected on April 27, 2025, impacting its on-premise network. The incident has temporarily disrupted manufacturing operations and the ability to process and ship customer orders.
Galiano Gold Drilling Uncovers New High-Grade Zone, Intercepts 50m @ 3.2 g/t Gold at Abore
Galiano Gold's latest drilling at the Abore deposit in Ghana uncovered a new high-grade zone with a significant intercept of 50 meters grading 3.2 g/t gold and confirmed extensions of existing high-grade mineralization at Abore South.
The results support the potential for underground mining and reinforce confidence in the current Mineral Reserve.
Collective Mining Hits 290 Meters at 0.84 g/t Gold Equivalent at San Antonio Pound Target
Collective Mining announced drill results, revealing a significant gold-copper porphyry discovery at its San Antonio Project's Pound target. Drill hole SAC-11 intersected 290.20 meters grading 0.84 g/t gold equivalent, prompting the company to mobilize two additional rigs for immediate follow-up drilling at Pound.
Profound Medical's CAPTAIN Trial Shows Zero Blood Loss, Shorter Hospital Stays vs. Robotic Prostatectomy
Profound Medical announced positive initial perioperative data from its CAPTAIN trial comparing the TULSA procedure to robotic radical prostatectomy. The data shows TULSA resulted in significantly less blood loss, shorter hospital stays, reduced pain, and faster recovery compared to robotic surgery in men with intermediate-risk prostate cancer.
MicroStrategy Raises $594 Million Selling Stock, Buys 6,911 Bitcoins at $84,529 Average Price
MicroStrategy sold nearly $600 million in stock to fund the purchase of 6,911 bitcoins at an average price of $84,529, increasing its total Bitcoin holdings to over 506,000. The company retains billions in stock available for future sales under existing agreements.
Vox Royalty: Gold Production Begins at Two Key Australian Assets
Vox Royalty announced the start of gold mining at the Plutonic East mine and Boundary deposit in Western Australia, assets covered by its royalties. This operational milestone signals the potential for new revenue generation from these assets.
Pilgrim's Pride Declares Massive $6.30 Dividend
Pilgrim's Pride declared a large $6.30 per share dividend for common stockholders, payable to holders of record on April 3, 2025. The company also held an Investor Day event on March 14, 2025, with presentation materials available in the related 8-K filing.
Protagonist & Takeda Announce Positive Phase 3 Rusfertide Results for Polycythemia Vera
Protagonist Therapeutics and Takeda Pharmaceuticals announced positive topline results for rusfertide in a Phase 3 trial for polycythemia vera on March 3, 2025. Further details are available in the exhibits to the SEC filing and a conference call presentation.
MicroStrategy Amasses Nearly 500,000 Bitcoins: Adds 20,356 BTC for $2 Billion Amidst New Convertible Note Offering
MicroStrategy further solidifies its position as a leading corporate Bitcoin holder, acquiring 20,356 more bitcoins for nearly $2 billion, funded by a new convertible note offering. The company's total Bitcoin holdings now approach half a million, with significant gains reported in early 2025 based on its proprietary BTC Yield, BTC Gain, and BTC $ Gain metrics.
MicroStrategy's $742 Million Bitcoin Buy: Holdings Surge to 478,740 BTC Amidst Debt Redemption
MicroStrategy's February 2025 8-K filing highlights a significant $742 million Bitcoin purchase, funded by share and preferred stock sales, increasing total holdings to 478,740 BTC and revealing a $1.785 billion Bitcoin Dollar Gain year-to-date.
Atossa Bolsters (Z)-Endoxifen IP with New Patent Amidst PTAB Ruling
Atossa Therapeutics announced a mixed intellectual property update, with the Patent Trial and Appeal Board ruling against one of its patents while simultaneously securing a new U.S. patent with 31 claims for its key drug, (Z)-endoxifen.
The company affirmed the PTAB decision would not impact its current clinical formulations and outlined plans to pursue further patent protection.
SSi Achieves World's First Robotic Cardiac Telesurgery
SS Innovations International successfully performed the world's first robotic cardiac telesurgery using its SSi Mantra 3 system, a significant leap forward in minimally invasive cardiac surgery.
Crinetics' Atumlenant Shows Promise in Phase 2 CAH Study
Crinetics Pharmaceuticals reported positive Phase 2 clinical trial results for its atumelnant drug candidate, intended for treating congenital adrenal hyperplasia and Cushing’s syndrome. The company shared its findings via press release and corporate presentation, and will hold a conference call on January 10th to elaborate.
Stoke Therapeutics to Launch Phase 3 Trial for Dravet Syndrome Treatment
Stoke Therapeutics is initiating a Phase 3 trial for zorevunersen to treat Dravet syndrome, aiming to provide the first disease-modifying therapy for this rare epilepsy. The trial, aligned with global regulatory agencies, will involve roughly 38,000 patients across seven major markets.
Lithium Americas' Thacker Pass: Massive Resource Expansion Unveiled, Signaling 85-Year Mine Life
Lithium Americas Corp. announced a massive increase in its Thacker Pass lithium reserves, supported by a detailed 85-year mine plan and a $2.3 billion DOE loan. This significant expansion of high-grade lithium deposits positions the company for substantial future lithium carbonate production.
Perpetua Resources Receives Final Approval for Stibnite Gold Project Mine Plan
Perpetua Resources received final approval for its Stibnite Gold Project mine plan, paving the way for construction once remaining permits and financing are secured. The decision, released on January 3, 2025, is a significant step forward for the company.
Sellas's GPS Trial Reaches 60 Deaths, Setting Stage for Pivotal AML Analysis
Sellas Life Sciences' pivotal Phase 3 REGAL trial for its AML drug, GPS, has reached its interim analysis trigger of 60 deaths, prompting a critical IDMC review in January 2025 that could determine the trial's future, including potential early stoppage for exceptional efficacy.
SSi Makes History: First in India to Secure Regulatory Approval for Telesurgery Robotic System
SS Innovations International achieved a major milestone, becoming the first company in India to gain regulatory approval for its telesurgery and teleproctoring surgical robotic system. This is expected to expand access to advanced surgical care and boost the company's position within the Indian market.
UEC's Q3 Report: $350 Million in Liquid Assets and Major Rio Tinto Acquisition
Uranium Energy Corp. (UEC) reported strong operational progress, including the restart of its Christensen Ranch mine and expansion of the Irigaray plant's capacity. The company also announced a major acquisition from Rio Tinto, significantly boosting its uranium resources and highlighting a robust financial position with over $350 million in liquid assets.
Rayonier Announces $722 Million Special Dividend
Rayonier Inc. announced a substantial one-time special dividend of $1.80 per share, totaling roughly $722 million, demonstrating strong financial health and commitment to shareholder returns.
Marathon Digital Spends $618 Million on Bitcoin at $95K Average Price, Launches $700 Million Debt Offering
Marathon Digital Holdings disclosed purchasing 6,484 bitcoins for $618.3 million at an average price of $95,352 per coin between October and November 2024 and announced a $700 million convertible note offering to fund the bitcoin purchase, repurchase existing debt, and for general corporate needs.
SSi Performs First Robotic Cardiac Surgery in Indonesia
SS Innovations International achieved a major medical breakthrough with the first robotic cardiac surgery in Indonesia using its SSi Mantra system. This successful procedure signifies a key step in global market expansion and positions SSi for future growth.
Maximus Loses Major Government Contract: HHS Cancels 1-800-MEDICARE Solicitation
Maximus announced the cancellation of a major government contract, impacting its financial projections and growth plans. The U.S. Department of Health and Human Services cancelled the solicitation, eliminating the possibility of Maximus winning the contract.
ASP Isotopes Completes Construction of Silicon-28 Enrichment Facility
ASP Isotopes completed construction and began commissioning a new silicon-28 enrichment facility, representing a significant expansion of its production capabilities and a key step in enhancing its market position.
Zeta Global (ZETA) Addresses Audit Committee Review in November 20, 2024 Filings
Zeta Global (ZETA) issued press releases on November 20, 2024, regarding an audit committee review, the details of which are contained in the referenced exhibits. The company's CFO signed the 8-K filing.
Red Cat Subsidiary Teal Drones Wins U.S. Army SRR Program of Record
Red Cat's subsidiary, Teal Drones, won the U.S. Army’s Short Range Reconnaissance Program of Record, a significant development aimed at providing portable, encrypted drones to all Army infantry platoons for battlefield awareness.
RLI Corp. Announces $4.00 Special Dividend and 2-for-1 Stock Split
RLI Corp. is returning significant value to shareholders with a special $4.00 per share dividend and a two-for-one stock split, effective January 16, 2025.
Stock Ideas
Uber (UBER): What flaw do Uber bulls miss with AVs and future cash flow?
Kohl's (KSS): Kohl's is less than 1/4th tangible book, privatization candidate - long
Duolingo (DUO): What do Duolingo shorts overlook?
Check stock ideas for blindspots, including bull and bear arguments. Free during our launch.
Submit press releases or stock ideas to see what management isn't saying or what Wall Street misses.
Free Analysis
We check stock ideas for possible blindspots. We also analyze earnings, presentations, news, dividends, and other stock events.
To celebrate our launch, analysis is free until July 31st.
Tag us on Twitter or Reddit for free analysis on any topic. To keep requests private, request via DM.
Twitter/X: @PanabeeAI
Reddit: @u/panabee_ai
Licensing
Our FAQs may be redistributed for online commercial purposes, provided you link back to Panabee.com and provide attribution. Link and attribution must occur on every page with our content, and above our content. For licensing other content, please contact us.
Disclosure
Our content is powered by AI and rarely involves an editor. This content may contain unintentional errors and omissions, especially with numbers. Our information is a starting point for independent research, not a recommendation to act.
Do not act on our information. This is not investment advice. This is not legal advice. Investing is risky and may cause severe financial loss. We are not licensed advisors. Despite our best effort, analysis and forward-looking statements may be wrong. Verify everything. See full disclaimer.
We may take and change financial positions at any time based on our analysis. Conflicts are disclosed on articles where we have a direct position. While our positions stem from genuine opinions, they may be inadvertently wrong.
AI Headshots
Sponsored
Turn 3 selfies into professional photos with AI Headshots.
Happiness guaranteed. Learn more.